Lonza, Hyglos sign licensing agreement for endotoxin detection patents
According to the deal, Hyglos will leverage Lonza’s patent-protected recombinant factor C technology in the production of endotoxin products. As part of the settlement, Lonza will cancel a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.